According to the Zhitong Finance App, Touyun Biotech (01332) announced the annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share.
According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.